Klotho Neurosciences Inc (NASDAQ: KLTO) is 23.71% higher on its value in year-to-date trading and has touched a low of $0.26 and a high of $13.10 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The KLTO stock was last observed hovering at around $0.70 in the last trading session, with the day’s loss setting it -0.1%.
Currently trading at $0.60, the stock is 25.29% and 37.73% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 13.36 million and changing -14.22% at the moment leaves the stock -80.49% off its SMA200. KLTO registered -94.38% loss for a year compared to 6-month loss of -60.00%. The firm has a 50-day simple moving average (SMA 50) of $0.43566 and a 200-day simple moving average (SMA200) of $3.0779.
The stock witnessed a 43.33% gain in the last 1 month and extending the period to 3 months gives it a 11.32%, and is 30.15% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 30.66% over the week and 17.58% over the month.
Klotho Neurosciences Inc (KLTO) has around 2 employees, a market worth around $10.94M and $0.00M in sales. Distance from 52-week low is 130.77% and -95.42% from its 52-week high. The company has generated returns on investments over the last 12 months (-235.89%).
.
Klotho Neurosciences Inc (KLTO) Top Institutional Holders
The shares outstanding are 19.86M, and float is at 16.49M with Short Float at 1.37%.
Klotho Neurosciences Inc (KLTO) Insider Activity
The most recent transaction is an insider sale by CHARDAN CAPITAL MARKETS LLC, the company’s 10% Owner. SEC filings show that CHARDAN CAPITAL MARKETS LLC sold 180,000 shares of the company’s common stock on Jul 02 ’24 at a price of $2.05 per share for a total of $0.37 million. Following the sale, the insider now owns 1.28 million shares.
Klotho Neurosciences Inc disclosed in a document filed with the SEC on Jul 01 ’24 that CHARDAN CAPITAL MARKETS LLC (10% Owner) sold a total of 115,136 shares of the company’s common stock. The trade occurred on Jul 01 ’24 and was made at $2.06 per share for $0.24 million. Following the transaction, the insider now directly holds 1.46 million shares of the KLTO stock.
Still, SEC filings show that on Jun 28 ’24, CHARDAN CAPITAL MARKETS LLC (10% Owner) disposed off 47,000 shares at an average price of $2.53 for $0.12 million. The insider now directly holds 1,579,500 shares of Klotho Neurosciences Inc (KLTO).
